M Volm

917 total citations
42 papers, 749 citations indexed

About

M Volm is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Volm has authored 42 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Volm's work include Cancer Treatment and Pharmacology (7 papers), Cancer Research and Treatments (5 papers) and Glutathione Transferases and Polymorphisms (5 papers). M Volm is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Cancer Research and Treatments (5 papers) and Glutathione Transferases and Polymorphisms (5 papers). M Volm collaborates with scholars based in Germany, United States and France. M Volm's co-authors include Silvia C. Formenti, W. Fraser Symmans, Franco M. Muggia, J Mattern, Sandra Demaria, Ruth Oratz, Richard L. Shapiro, Herman Yee, Jürgen Mattern and Reet Koomägi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

M Volm

39 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Volm Germany 13 459 293 176 175 126 42 749
G Mariani Italy 14 561 1.2× 378 1.3× 230 1.3× 117 0.7× 275 2.2× 33 917
M. J. Duffy Ireland 12 268 0.6× 280 1.0× 56 0.3× 195 1.1× 88 0.7× 22 650
Andrea Milani Italy 12 416 0.9× 268 0.9× 109 0.6× 123 0.7× 208 1.7× 35 765
Herbert L. Kotz United States 13 363 0.8× 429 1.5× 165 0.9× 128 0.7× 140 1.1× 24 1.0k
Denise McLain United States 14 288 0.6× 240 0.8× 157 0.9× 105 0.6× 223 1.8× 32 690
Z Estrov United States 15 287 0.6× 335 1.1× 233 1.3× 112 0.6× 45 0.4× 17 1.1k
Peter Häusler Germany 10 527 1.1× 352 1.2× 121 0.7× 87 0.5× 128 1.0× 14 820
Shane K. Green Canada 7 378 0.8× 462 1.6× 90 0.5× 233 1.3× 117 0.9× 9 795
Emma Kipps United Kingdom 8 292 0.6× 268 0.9× 125 0.7× 157 0.9× 94 0.7× 26 693
Masanori Kanemura Japan 18 309 0.7× 415 1.4× 86 0.5× 193 1.1× 98 0.8× 37 920

Countries citing papers authored by M Volm

Since Specialization
Citations

This map shows the geographic impact of M Volm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Volm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Volm more than expected).

Fields of papers citing papers by M Volm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Volm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Volm. The network helps show where M Volm may publish in the future.

Co-authorship network of co-authors of M Volm

This figure shows the co-authorship network connecting the top 25 collaborators of M Volm. A scholar is included among the top collaborators of M Volm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Volm. M Volm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickler, Maura N., M Volm, Yelena Novik, et al.. (2011). Reduction of serum VEGF and IL-6 levels in patients with metastatic breast cancer: Results of a study of PTC299, an oral inhibitor of tumor VEGF synthesis, and aromatase inhibitors.. Journal of Clinical Oncology. 29(15_suppl). 1100–1100. 1 indexed citations
2.
3.
Fink, Michael, Anne C. Pavlick, Kathleen Farrell, et al.. (2004). A phase II trial of DTIC with thalidomide (thal) in metastatic melanoma (MM). Journal of Clinical Oncology. 22(14_suppl). 7543–7543.
4.
Hamilton, Anne & M Volm. (2001). Nonsteroidal and steroidal aromatase inhibitors in breast cancer.. PubMed. 15(8). 965–72; discussion 972, 977. 17 indexed citations
5.
Mattern, J, Reet Koomägi, & M Volm. (1999). Xenotransplantability of human squamous cell lung cancer in nude mice is not affected by angiogenic factors.. PubMed. 19(3A). 1941–3. 3 indexed citations
6.
7.
Kallinowski, F., et al.. (1996). Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. International Journal of Cancer. 67(1). 20–23. 44 indexed citations
8.
Koomägi, Reet, Jürgen Mattern, & M Volm. (1995). Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis. 16(9). 2129–2133. 13 indexed citations
9.
Sauerbrey, Axel, M Volm, & F Zintl. (1995). Expression und klinische Bedeutung von Resistenz-Proteinen bei initialer akuter lymphatischer Leukämie (ALL) im Kindesalter. Klinische Pädiatrie. 207(4). 230–234. 3 indexed citations
10.
Volm, M, et al.. (1995). Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer. Lung Cancer. 13(2). 218–218. 10 indexed citations
11.
12.
Volm, M, et al.. (1993). Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis. 14(6). 1121–1124. 41 indexed citations
13.
14.
Mattern, J & M Volm. (1992). Prediction of drug resistance in human tumors using immunohistochemical techniques.. PubMed. 12(2). 413–8. 5 indexed citations
15.
Mattern, J, et al.. (1989). Radiosensitivity of drug-resistant human tumour xenografts.. PubMed. 165(12). 870–2. 2 indexed citations
16.
Volm, M, et al.. (1988). DNA and S‐phase distribution and incidence of metastasis in human primary lung carcinoma. Cytometry. 9(2). 183–188. 30 indexed citations
17.
Volm, M & W. Kleine. (1987). Prognostische Bedeutung von durchflußzytophotometrischen Untersuchungen beim Ovarialkarzinom. Geburtshilfe und Frauenheilkunde. 47(7). 456–459. 2 indexed citations
18.
Volm, M & J Mattern. (1976). [Individual chemotherapy of solid tumors].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(24). 1171–6. 5 indexed citations
19.
Volm, M, Michael Kaufmann, J Mattern, & K. Wayss. (1975). [Sensitivity tests of malignant tumours against cytostatic agents in vitro and in vivo/studies on the mouse sarcoma 180 (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(7). 1042–8. 1 indexed citations
20.
Volm, M, K Goerttler, J Mattern, K. Wayss, & Martin Kaufmann. (1974). [Proceedings: Pretherapeutic sensitivity testing for chemotherapy of tumors].. PubMed. 58. 509–509. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Mariani Breakdown of academic impact, for papers by M. J. Duffy Breakdown of academic impact, for papers by Andrea Milani Breakdown of academic impact, for papers by Herbert L. Kotz Breakdown of academic impact, for papers by Denise McLain Breakdown of academic impact, for papers by Z Estrov Breakdown of academic impact, for papers by Peter Häusler Breakdown of academic impact, for papers by Shane K. Green Breakdown of academic impact, for papers by Emma Kipps Breakdown of academic impact, for papers by Masanori Kanemura
Rankless by CCL
2026